Back
HFA Premium Access

Discussant review - FAIR-HFpEF

Session: Late breaking clinical trials: further analyses and baseline characteristics
Topic: Treatment
Speaker: Professor P. Kalra (Portsmouth, GB)
Event: Heart Failure 2024

Congress Presentation

About the speaker

Professor Paul Kalra

Queen Alexandra Hospital, Portsmouth (United Kingdom of Great Britain & Northern Ireland)
9 presentations
3 followers

9 more presentations in this session

Effect of IV iron in patients with heart failure with preserved ejection fraction

Speaker: Professor S. von Haehling (Goettingen, DE)

Access
Slides
Video
Thumbnail

Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF: insights from the STEP-HFpEF programme

Speaker: Professor M. Petrie (Glasgow, GB)

Access
Slides
Video
Thumbnail

Discussant review - STEP HFpEF Program

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Access
Slides
Video
Thumbnail

Design and baseline characteristics of REALIZE K: a placebo-controlled randomized-withdrawal trial of sodium zirconium cyclosilicate for hyperkalaemia management in patients with HF and reduced EF

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access
Slides
Video
Thumbnail

Discussant review - REALIZE-K

Speaker: Professor G. Rosano (London, GB)

Access
Slides
Video
Thumbnail

Access the full session

Late breaking clinical trials: further analyses and baseline characteristics

Speakers: Professor P. Kalra, Professor S. von Haehling, Professor M. Petrie, Doctor A. Bayes Genis, Doctor M. Kosiborod...
Access
Video
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources